Class information for:
Level 1: MEDULLARY THYROID CARCINOMA//RET PROTO ONCOGENE//MEDULLARY THYROID CANCER

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
1180 2701 32.6 74%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
35 32606 THYROID CANCER//THYROID//THYROGLOBULIN

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MEDULLARY THYROID CARCINOMA Author keyword 427 64% 15% 418
2 RET PROTO ONCOGENE Author keyword 154 69% 5% 132
3 MEDULLARY THYROID CANCER Author keyword 76 50% 4% 109
4 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 Author keyword 75 71% 2% 60
5 C CELL HYPERPLASIA Author keyword 63 78% 2% 42
6 RET MUTATION Author keyword 62 92% 1% 24
7 PROPHYLACTIC THYROIDECTOMY Author keyword 61 95% 1% 20
8 RET PROTOONCOGENE Author keyword 57 69% 2% 49
9 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B Author keyword 55 92% 1% 22
10 MULTIPLE ENDOCRINE NEOPLASIA Author keyword 46 36% 4% 104

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 MEDULLARY THYROID CARCINOMA 427 64% 15% 418 Search MEDULLARY+THYROID+CARCINOMA Search MEDULLARY+THYROID+CARCINOMA
2 RET PROTO ONCOGENE 154 69% 5% 132 Search RET+PROTO+ONCOGENE Search RET+PROTO+ONCOGENE
3 MEDULLARY THYROID CANCER 76 50% 4% 109 Search MEDULLARY+THYROID+CANCER Search MEDULLARY+THYROID+CANCER
4 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 75 71% 2% 60 Search MULTIPLE+ENDOCRINE+NEOPLASIA+TYPE+2 Search MULTIPLE+ENDOCRINE+NEOPLASIA+TYPE+2
5 C CELL HYPERPLASIA 63 78% 2% 42 Search C+CELL+HYPERPLASIA Search C+CELL+HYPERPLASIA
6 RET MUTATION 62 92% 1% 24 Search RET+MUTATION Search RET+MUTATION
7 PROPHYLACTIC THYROIDECTOMY 61 95% 1% 20 Search PROPHYLACTIC+THYROIDECTOMY Search PROPHYLACTIC+THYROIDECTOMY
8 RET PROTOONCOGENE 57 69% 2% 49 Search RET+PROTOONCOGENE Search RET+PROTOONCOGENE
9 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B 55 92% 1% 22 Search MULTIPLE+ENDOCRINE+NEOPLASIA+TYPE+2B Search MULTIPLE+ENDOCRINE+NEOPLASIA+TYPE+2B
10 MULTIPLE ENDOCRINE NEOPLASIA 46 36% 4% 104 Search MULTIPLE+ENDOCRINE+NEOPLASIA Search MULTIPLE+ENDOCRINE+NEOPLASIA

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MEN 2A 637 91% 10% 264
2 FMTC 315 88% 5% 148
3 PROPHYLACTIC THYROIDECTOMY 292 88% 5% 136
4 MEDULLARY THYROID CARCINOMA 259 43% 17% 460
5 SERUM CALCITONIN 239 78% 6% 156
6 C CELL HYPERPLASIA 207 78% 5% 135
7 PROTOONCOGENE MUTATIONS 163 88% 3% 78
8 ROUTINE MEASUREMENT 141 68% 5% 123
9 RET PROTOONCOGENE 132 31% 13% 351
10 NEOPLASIA TYPE 2A 107 67% 4% 96

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association 2009 423 328 74%
RET revisited: expanding the oncogenic portfolio 2014 35 187 44%
Guidelines for diagnosis and therapy of MEN type 1 and type 2 2001 836 132 43%
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update 2013 30 142 74%
Medullary thyroid cancer diagnosis: An appraisal 2014 5 79 91%
Medullary thyroid carcinoma 2004 133 49 88%
RET proto-oncogene in the development of human cancer 1999 182 113 78%
Update on the Cytologic and Molecular Features of Medullary Thyroid Carcinoma 2014 7 86 65%
Genotype-phenotype correlation in multiple endocrine neoplasia type 2 2012 13 33 100%
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form 2013 11 94 94%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 GEN VISCERAL VASC SURG 7 13% 1.8% 49
2 CHARLIE HAYS CANC 6 100% 0.1% 4
3 ONCOL UROL SURG 3 100% 0.1% 3
4 PLA HOSP 117 3 100% 0.1% 3
5 HIGH TECHNOL STUDY ENVIRONM DAMAGE ENDOCRINE 3 31% 0.3% 8
6 UMR 5641 3 29% 0.3% 8
7 UNIDAD GENET MED DIAGNOST PRENATAL 3 35% 0.2% 6
8 HUMAN CANC GENET GRP 3 14% 0.6% 17
9 AMBISEN 3 24% 0.3% 9
10 SECT ENDOCRINOL DIABETOL 2 23% 0.3% 9

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000137478 ANAPLASTIC THYROID CANCER//ANAPLASTIC THYROID CARCINOMA//LENVATINIB
2 0.0000107108 C CELLS//TT CELLS//CALCITONIN SECRETION
3 0.0000102548 ENDOCRINE SURG S//ACHAETE SCUTE COMPLEX LIKE 1//CLIN SCI H4 750
4 0.0000073915 RET PTC//PAPILLARY THYROID CARCINOMA//HBME 1
5 0.0000071817 TC 99M V DMSA//BIOPHYS RADIOPHARMACEUT//TC 99M VDMSA
6 0.0000067977 SOLID CELL NESTS//THYROID METASTASIS//ULTIMOBRANCHIAL BODY
7 0.0000067154 PARATHYROID CARCINOMA//MENIN//MEN1
8 0.0000064065 GDNF//GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR//NEURTURIN
9 0.0000060872 UNIT ENVIRONM HLTH SCI//UNITS ENVIRONM HLTH SCI//REACTIVE POLYESTER
10 0.0000056833 HIRSCHSPRUNG DISEASE//INTESTINAL NEURONAL DYSPLASIA//AGANGLIONOSIS